The store will not work correctly when cookies are disabled.
N-(2-chlorophenyl)-1-methyl-1H-indole-3-carboxamide
ID: ALA1078145
PubChem CID: 29195497
Max Phase: Preclinical
Molecular Formula: C16H13ClN2O
Molecular Weight: 284.75
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cn1cc(C(=O)Nc2ccccc2Cl)c2ccccc21
Standard InChI: InChI=1S/C16H13ClN2O/c1-19-10-12(11-6-2-5-9-15(11)19)16(20)18-14-8-4-3-7-13(14)17/h2-10H,1H3,(H,18,20)
Standard InChI Key: HJUCTCWVRRKZSQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
-4.5527 -7.9158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5539 -8.7427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8395 -9.1552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8413 -7.5033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1264 -7.9122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1215 -8.7381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3345 -8.9887 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.8529 -8.3176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3424 -7.6524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3253 -6.8299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6040 -6.4307 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.0318 -6.4048 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.0168 -5.5804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2908 -5.1845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2755 -4.3610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9801 -3.9422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7062 -4.3386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7179 -5.1608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4381 -5.5624 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.0752 -9.7713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 1 1 0
9 10 1 0
5 6 1 0
10 11 2 0
10 12 1 0
2 3 1 0
12 13 1 0
3 6 2 0
13 14 2 0
1 2 2 0
14 15 1 0
5 4 2 0
15 16 2 0
6 7 1 0
16 17 1 0
7 8 1 0
17 18 2 0
18 13 1 0
8 9 2 0
18 19 1 0
9 5 1 0
7 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 284.75 | Molecular Weight (Monoisotopic): 284.0716 | AlogP: 4.08 | #Rotatable Bonds: 2 |
Polar Surface Area: 34.03 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.99 | CX LogD: 3.99 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.76 | Np Likeness Score: -1.73 |
References
1. Qiao L, Choi S, Case A, Gainer TG, Seyb K, Glicksman MA, Lo DC, Stein RL, Cuny GD.. (2009) Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors., 19 (21): [PMID:19783434] [10.1016/j.bmcl.2009.09.010] |